Skip to main content
Premium Trial:

Request an Annual Quote

New Rules: Jul 7, 2009

NIH issued the final rules for federally sponsored embryonic stem cell research and they become effective today. Older lines may still be eligible for use. "Many of the lines already in existence may have met very rigorous standards of informed consent but may have been implemented in ways not consistent with the present guidelines," Dr. Kington says. "It's unreasonable to retroactively apply procedures intended for future use." The New York Times says that "the crucial test is whether the embryos used to create the stem cell lines were created for reproductive purposes, and whether donors freely consented for their use in research procedures." NIH will create a registry of which lines meet its eligibility requirements.

The Chronicle of Higher Education says that the new guidelines "won immediate endorsement from researchers and university groups, including the Association of American Medical Colleges and the Association of American Universities."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.